Alm. Brand – weekly report on share buybacks In the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Alm. Brand – weekly report on share buybacks

In the period 2 December 2015 to 4 December 2015, Alm. Brand bought own shares for a total amount of DKK 5,2 million as part of the share buyback programme of up to DKK 300 million announced on 1 December 2015. In aggregate, shares of DKK 5.2 million have been bought back, equivalent to 1.7% of the overall programme.

Under the share buyback programme, the following transactions were made during the period:

Date No. of shares Average purchase price (DKK) Transaction value  (DKK)
2 December 2015 35,714 46.34 1,654,987
3 December 2015 38,095 46.64 1,776,751
4 December 2015 38,095 46.65 1,777,132
Accumulated during the period 111,904 46.55 5,208,869

Danske Bank manages the share buyback programme, which is completed as a Safe Harbour scheme in accordance with Commission Regulation (EC) No. 2273/2003 of 22 December 2003.

Following the above transactions, Alm. Brand holds 4,555,396 own shares, equivalent to 2.6% of the share capital.

Contact

Please direct any questions regarding this announcement to:

Martin Egenhardt, IR Manager, on tel. +45 35 47 79 22.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Important Legal Opportunity for Coinbase Investors in Class Action

Updated Category News Views 114

Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...

Continue Reading
BridGene Biosciences Secures $28 Million for Drug Development

Updated Category News Views 244

BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...

Continue Reading
NMD Pharma Breaks Ground with NMD670 in Rare Neuromuscular Treatment

Updated Category News Views 177

NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...

Continue Reading
Becker Milk Company Limited Announces Half-Year Financial Overview

Updated Category News Views 89

Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...

Continue Reading
Mini Melts Collaborates with 7-Eleven for Blue Raspberry Flavor

Updated Category News Views 354

Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...

Continue Reading